Weibo Corp vs GeneDx Holdings Corp — how do they compare? Weibo Corp trades at $7.74 (market cap $1.93B), while GeneDx Holdings Corp trades at $82.34 (market cap $2.44B). The key difference: GeneDx Holdings Corp is the larger of the two by market cap, and Weibo Corp pays a 7.75% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WB | WGS | |
|---|---|---|
Market Cap | $1.93B | $2.44B |
Sector | Media | Technology |
52-Week High | $12.83 | $167.51 |
52-Week Low | $7.20 | $34.51 |
Enterprise Value | $1.20B | $2.48B |
Dividend Yield | 7.75% | — |
Signals from Pluang's Aura AI — not financial advice
Weibo (WB) trades at $7.74, down 3.01% in the last session, with a bearish technical signal and recent earnings misses. The stock shows strong fundamentals with a low P/E of 5.5 and robust net income margin of 21.15%, while cash flow trends improved in 2025. Recent news highlights Q2 2026 results anticipation and AI developments, but competitive pressures persist.
The outlook is mixed; valuation metrics suggest undervaluation with analyst support, but earnings volatility and market sentiment risks require caution. Opportunities lie in cash flow strength and balance sheet health, while risks include user engagement challenges and macroeconomic headwinds in the social media sector.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Trailing returns across standard periods
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →